✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Roivant Sciences Ltd

Common Name
Roivant Sciences
Country
United Kingdom
Sector
Healthcare
Industry
Biotechnology
Employees
750
Ticker
ROIV
Exchange
NASDAQ/NGS
Description
Roivant Sciences Ltd is a biopharmaceutical company focused on developing and commercializing innovative therapies through a unique model that emphasizes rapid and efficient drug delivery. As a platfo...

Roivant Sciences's Financial Statements Preview

Below are the financial statements of Roivant Sciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2025 as of 2025-03-31
2024 as of 2024-03-31
Assets
Current assets
Cash and cash equivalents
2,715.41a
6,494.95a
Marketable securities
2,171.48a
0a
Other current assets
113.17a
80.61a
Current assets of discontinued operations
0a
156.27a
Total current assets
5,000.06a
6,731.83a
Property and equipment, net
12.06a
15.32a
Operating lease right-of-use assets
89.02a
44a
Investments measured at fair value
302.94a
247.75a
Other assets
32.86a
37.7a
Noncurrent assets of discontinued operations
0a
145.88a
Total assets
5,436.94a
7,222.48a
Liabilities and shareholders’ equity
Current liabilities
Accounts payable
23.69a
14.03a
Accrued expenses
114.29a
119.42a
Operating lease liabilities
9.84a
8.97a
Other current liabilities
1.58a
13.94a
Current liabilities of discontinued operations
0a
110.41a
Total current liabilities
149.41a
266.76a
Liability instruments measured at fair value
9.98a
25.74a
Operating lease liabilities, noncurrent
90.33a
45.02a
Other liabilities
0.02a
2.49a
Noncurrent liabilities of discontinued operations
0a
433.95a
Total liabilities
249.74a
773.95a
Shareholders’ equity
Common shares
0a
0a
Additional paid-in capital
4,562.11a
5,396.49a
Retained earnings
116.06a
576.17a
Accumulated other comprehensive income (loss)
9.44a
-4.08a
Shareholders’ equity attributable to Roivant Sciences Ltd.
4,687.61a
5,968.58a
Noncontrolling interests
499.59a
479.95a
Total shareholders’ equity
5,187.2a
6,448.53a
Total liabilities and shareholders’ equity
5,436.94a
7,222.48a
Limited Data Preview
You are viewing a limited preview of Roivant Sciences’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Roivant Sciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Roivant Sciences’s data sources below and access millions more through our Disclosure Search.

a. Roivant Sciences's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?